Abstract
Background
Corneal collagen cross-linking (CXL), a technique that combines riboflavin administration with long-wave ultraviolet light irradiation, was primarily developed to increase the biomechanical strength of collagen fibrils of the cornea to avoid the progression of keratoconus. Recently, this method has been proposed to treat selected cases of infectious keratitis.
Methods
To test the protocol used for progressive keratoconus in infectious keratitis, Candida albicans, and Fusarium solani, strains were exposed to irradiation using a wavelength of 365 nm at a power density of 3 mW/cm2 for 30 min in the presence of riboflavin photosensitizer. All experiments were performed in triplicate. Qualitative and quantitative measurements of fungal viability used plate cultures and an automated trypan blue dye exclusion method respectively. Fungal cell diameter was also assessed in all groups. Statistical analyses were performed using the triplicate values of each experimental condition.
Results
Experimental findings of photodynamic therapy applied to the cell inactivation of both yeasts and filamentous fungi were compared with control groups. Qualitative results were corroborated with quantitative findings which showed no statistical significance between challenged samples (experimental groups) and the control group (p-value = 1). In comparison with a control group of live cells, statistical significance was observed when riboflavin solution alone had an effect on the morphologic size of filamentous fungi, while ultraviolet light irradiation alone showed a slight decrease in the cell structure of C. albicans.
Conclusions
The impact of long-wave ultraviolet combined with riboflavin photosensitizer showed no antifungal effect on C. albicans and F. solani. The significant decrease in cell morphology of both filamentous fungi and yeasts submitted to photosensitizing riboflavin and exposure to ultraviolet light, respectively, may be promising in the development and standardization of alternatives for fungal cell inactivation, because of their minimal cytotoxic effects on the corneal surface. The methodological improvement in the preparation and application of individual chemical compounds, such as riboflavin, or physical systems, such as a long-wave light source, as antifungal agents may also assist in establishing promising therapeutic procedures for keratomycosis.
Similar content being viewed by others
References
Tuli SS (2011) Fungal keratitis. Clin Ophthalmol 5:275–279
Gopinathan U, Sharma S, Garg P, Rao GN (2009) Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian J Ophthalmol 57(4):273–279
Chang HY, Chodosh J (2011) Diagnostic and therapeutic considerations in fungal keratitis. Int Ophthalmol Clin 51(4):33–42
Mselle J (1999) Fungal keratitis as an indicator of HIV infection in Africa. Trop Doct 29(3):133–135
Thomas PA (2003) Fungal infections of the cornea. Eye (Lond) 17(8):852–862
Ganegoda N, Rao SK (2004) Antifungal therapy for keratomycoses. Expert Opin Pharmacother 5(4):865–874
Kalkanci A, Ozdek S (2011) Ocular fungal infections. Curr Eye Res 36(3):179–189
Vemuganti GK, Garg P, Gopinathan U, Naduvilath TJ, John RK, Buddi R, Rao GN (2002) Evaluation of agent and host factors in progression of mycotic keratitis: a histologic and microbiologic study of 167 corneal buttons. Ophthalmology 109(8):1538–1546
Wollensak G, Sporl E, Seiler T (2003) Treatment of keratoconus by collagen cross linking. Ophthalmologe 100(1):44–49
Iseli HPTM, Hafezi F, Kampmeier J, Seiler T (2008) Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 27(5):590–594
Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A (2011) Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 118(2):324–331
Makdoumi KMJ, Crafoord S (2010) Infectious keratitis treated with corneal crosslinking. Cornea 29(12):1353–1358
Micelli Ferrari TLM, Lorusso M, Epifani E, Micelli Ferrari L (2009) Escherichia coli keratitis treated with ultraviolet A/riboflavin corneal cross-linking: a case report. Eur J Ophthalmol 19(2):295–297
Moren HMM, Mortensen J, Ohrstrom A (2010) Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea 29(1):102–104
Lonnen J, Kilvington S, Kehoe SC, Al-Touati F, McGuigan KG (2005) Solar and photocatalytic disinfection of protozoan, fungal and bacterial microbes in drinking water. Water Res 39(5):877–883
Spoerl EMM, Sliney D, Trokel S, Seiler T (2007) Safety of UVA-riboflavin cross-linking of the cornea. Cornea 26:385–389
Ibrahim MM, de Angelis R, Lima AS, Viana de Carvalho GD, Ibrahim FM, Malki LT, de Paula Bichuete M, de Paula Martins W, Rocha EM (2012) A new method to predict the epidemiology of fungal keratitis by monitoring the sales distribution of antifungal eye drops in Brazil. PLoS One 7(3):e33775
Matsumoto YMD, Kojima T, Shimazaki J, Tsubota K (2011) The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br J Ophthalmol 95(10):1406–1409
Yavas GFOF, Küsbeci T, Cetinkaya Z, Ermis SS, Kiraz N, Inan UU (2008) Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis. Graefes Arch Clin Exp Ophthalmol 246(2):275–279
Martin MJ, Rahman MR, Johnson GJ, Srinivasan M, Clayton YM (1995) Mycotic keratitis: susceptibility to antiseptic agents. Int Ophthalmol 19(5):299–302
Al-Sabai NKC, Tassignon MJ (2010) UVA/riboflavin crosslinking as treatment for corneal melting. Bull Soc Belge Ophtalmol 315:13–17
Makdoumi KMJ, Sorkhabi O, Malmvall BE, Crafoord S (2012) UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol 250(1):95–102
Rama PDMF, Matuska S, Paganoni G, Spinelli A (2009) Acanthamoeba keratitis with perforation after corneal crosslinking and bandage contact lens use. J Cataract Refract Surg 35(4):788–791
Kashiwabuchi RT, Carvalho FR, Khan YA, de Freitas D, Foronda AS, Hirai FE, Campos MS, McDonnell PJ (2011) Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Invest Ophthalmol Vis Sci 52(13):9333–9338
Wiwanitkit V (2010) Bactericidal effect of photo-activated riboflavin using UVA. Graefes Arch Clin Exp Ophthalmol 248(5):755
del Buey MACJ, Casas P, Goñi P, Clavel A, Mínguez E, Lanchares E, García A, Calvo B (2012) Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. Am J Ophthalmol 153(3):399–404
Martins SACJ, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A (2008) Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49(8):3402–3408
Sauer AL-BV, Speeg-Schatz C, Touboul D, Colin J, Candolfi E, Bourcier T (2010) In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Invest Ophthalmol Vis Sci 51(8):3950–3953
Ou JI, Acharya NR (2007) Epidemiology and treatment of fungal corneal ulcers. Int Ophthalmol Clin 47(3):7–16
Ritterband DCSJ, Shah MK, Koplin RS, McCormick SA (2006) Fungal keratitis at the New York eye and ear infirmary. Cornea 25:264–267
Strober W (2001) Trypan blue exclusion test of cell viability. Curr Protoc Immunol Appendix 3: Appendix 3B
Szentmáry NGS, Bischoff M, Seitz B (2012) Photodynamic therapy for infectious keratitis. Ophthalmologe 109(2):165–170
Chen ZXS, Zhiqun W, Ran L (2008) In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba. Br J Ophthalmol 92(9):1283–1286
Shih MHHF (2011) Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Invest Ophthalmol Vis Sci 52(1):223–229
Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135(5):620–627
Sudhir PV, Ranjan DS, Ganpat AN (2010) Antifungal agents, WO2009025733. Expert Opin Ther Pat 20(1):137–143
Espinel-Ingroff A (2009) Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005–2009). Rev Iberoam Micol 26(1):15–22
Bartnicki-Garcia S (1968) Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu Rev Microbiol 22:87–108
Adams DJ (2004) Fungal cell wall chitinases and glucanases. Microbiology 150(Pt 7):2029–2035
Nakagawa Y (2008) Catalase gene disruptant of the human pathogenic yeast Candida albicans is defective in hyphal growth, and a catalase-specific inhibitor can suppress hyphal growth of wild-type cells. Microbiol Immunol 52(1):16–24
Kaplan JGPW (1956) The action of ultraviolet radiation on yeast catalase. J Gen Physiol 40(1):147–169
Cornforth JWRG, Robinson PM, Park D (1971) Isolation and characterization of a fungal vacuolation factor (bikaverin). J Chem Soc Perkin 1(16):2786–2788
Roberts J (1923) A budrot of the peach caused by a species of fusarium. J Agric Res XXVI(10):507–513
Taff HT NJ, Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR (2012) A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog 8:(e1002848):
Li JHK, Yumoto H, Matsuo T, Miyake Y, Ichikawa T (2010) Enhanced germicidal effects of pulsed UV-LED irradiation on biofilms. J Appl Microbiol 109:2183–2190
Baillie GSDL (2000) Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46:397–403
Marcinkowska JKJ, Marquis LY (1982) Phytotoxic effects of cell-free cultural filtrates of Fusarium solani isolates on virulence, host specificity and resistance. Can J Plant Sci 62:1027–1035
Acknowledgments
The authors acknowledge a financial support given by an unrestricted grant from Research to Prevent Blindness Inc, NY, NY to the Wilmer Ophthalmological Institute to conduct this study (laboratory supplies).
Financial support
Research to Prevent Blindness Inc, New York, NY provided financial support to the Wilmer Ophthalmological Institute to conduct this study (laboratory supplies). Fabio RS Carvalho was supported by a postdoctoral fellowship from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (PNPD/CAPES).
Conflict of interest
No conflicting relationship exists for any author.
Author information
Authors and Affiliations
Corresponding author
Additional information
All authors have full control of all primary data, and we agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review our data upon request.
Rights and permissions
About this article
Cite this article
Kashiwabuchi, R.T., Carvalho, F.R.S., Khan, Y.A. et al. Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration. Graefes Arch Clin Exp Ophthalmol 251, 521–527 (2013). https://doi.org/10.1007/s00417-012-2209-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-012-2209-z